Michael D. Stensland

1.5k total citations
30 papers, 1.1k citations indexed

About

Michael D. Stensland is a scholar working on Psychiatry and Mental health, Physiology and Social Psychology. According to data from OpenAlex, Michael D. Stensland has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 9 papers in Physiology and 6 papers in Social Psychology. Recurrent topics in Michael D. Stensland's work include Schizophrenia research and treatment (14 papers), Bipolar Disorder and Treatment (11 papers) and Mental Health Treatment and Access (6 papers). Michael D. Stensland is often cited by papers focused on Schizophrenia research and treatment (14 papers), Bipolar Disorder and Treatment (11 papers) and Mental Health Treatment and Access (6 papers). Michael D. Stensland collaborates with scholars based in United States, China and Australia. Michael D. Stensland's co-authors include Kenneth A. Holroyd, Gary E. Cordingley, Haya Ascher‐Svanum, Francis O’Donnell, Bruce W. Carlson, Gay L. Lipchik, Bruce J. Kinon, Gay L. Lipchik, Kimberly R. Hill and Peter R. Watson and has published in prestigious journals such as JAMA, Journal of Affective Disorders and Medical Care.

In The Last Decade

Michael D. Stensland

28 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael D. Stensland United States	16	786	241	196	160	156	30	1.1k
Tamás Treuer United States	21	1.1k 1.4×	128 0.5×	137 0.7×	306 1.9×	114 0.7×	88	1.4k
Marloes Gerrits Netherlands	11	343 0.4×	188 0.8×	419 2.1×	134 0.8×	61 0.4×	18	1.1k
Shiang-Ru Lu Taiwan	19	995 1.3×	296 1.2×	108 0.6×	220 1.4×	479 3.1×	22	1.6k
Ellen Bazelmans Netherlands	18	909 1.2×	79 0.3×	254 1.3×	134 0.8×	45 0.3×	31	1.6k
Poonam Gardner-Sood United Kingdom	19	514 0.7×	144 0.6×	44 0.2×	185 1.2×	105 0.7×	35	864
Vineeth John United States	4	631 0.8×	329 1.4×	131 0.7×	126 0.8×	30 0.2×	5	1.2k
Jamie Kane United States	6	887 1.1×	66 0.3×	144 0.7×	284 1.8×	57 0.4×	13	1.2k
Monika Löfgren Sweden	23	799 1.0×	260 1.1×	754 3.8×	93 0.6×	103 0.7×	74	1.4k
Michael S. Shutty United States	18	420 0.5×	180 0.7×	381 1.9×	122 0.8×	83 0.5×	42	1.1k
Malcolm H. Johnson New Zealand	19	300 0.4×	267 1.1×	461 2.4×	300 1.9×	160 1.0×	36	1.4k

Countries citing papers authored by Michael D. Stensland

Since Specialization

Citations

This map shows the geographic impact of Michael D. Stensland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Stensland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Stensland more than expected).

Fields of papers citing papers by Michael D. Stensland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Stensland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Stensland. The network helps show where Michael D. Stensland may publish in the future.

Co-authorship network of co-authors of Michael D. Stensland

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Stensland. A scholar is included among the top collaborators of Michael D. Stensland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Stensland. Michael D. Stensland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Donohue, James F., Vamsi Bollu, Donald E. Stull, et al.. (2018). Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial. International Journal of COPD. Volume 13. 499–508. 3 indexed citations

Ganapathy, Vaidyanathan & Michael D. Stensland. (2017). Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol. International Journal of COPD. Volume 12. 1793–1801. 6 indexed citations

Stensland, Michael D., et al.. (2014). Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China. Neuropsychiatric Disease and Treatment. 10. 869–869. 4 indexed citations

Montgomery, William, Tamás Treuer, Wenyu Ye, et al.. (2014). Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?. Neuropsychiatric Disease and Treatment. 10. 1287–1287.

Montgomery, William, Liu, Haya Ascher‐Svanum, et al.. (2013). The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy. ClinicoEconomics and Outcomes Research. 5. 407–407. 27 indexed citations

Stensland, Michael D., et al.. (2010). Depression diagnoses following the identification of bipolar disorder: costly incongruent diagnoses. BMC Psychiatry. 10(1). 39–39. 20 indexed citations

Ivanova, Jasmina, Howard G. Birnbaum, Yohanne Kidolezi, et al.. (2010). Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder. Current Medical Research and Opinion. 26(10). 2475–2484. 103 indexed citations

Kashner, T. Michael, Michael D. Stensland, Lisa Lind, et al.. (2009). Measuring Use and Cost of Care for Patients With Mood Disorders. Medical Care. 47(2). 184–190. 10 indexed citations

Yu, Andrew P., et al.. (2009). Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid population. Current Medical Research and Opinion. 25(3). 755–764. 11 indexed citations

10.

Stensland, Michael D., et al.. (2008). Diagnosis of Unipolar Depression Following Initial Identification of Bipolar Disorder. The Journal of Clinical Psychiatry. 69(5). 749–758. 39 indexed citations

11.

Stensland, Michael D., Jennie G. Jacobson, & Allen W. Nyhuis. (2007). Service utilization and associated direct costs for bipolar disorder in 2004: An analysis in managed care. Journal of Affective Disorders. 101(1-3). 187–193. 49 indexed citations

12.

Zhu, Baojin, Pandurang M. Kulkarni, Michael D. Stensland, & Haya Ascher‐Svanum. (2007). Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder. Current Medical Research and Opinion. 23(11). 2805–2814. 13 indexed citations

13.

Tunis, Sandra L., Douglas E. Faries, Michael D. Stensland, Donald P. Hay, & Bruce J. Kinon. (2006). An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophrenia. Current Medical Research and Opinion. 23(1). 97–104. 22 indexed citations

14.

Ascher‐Svanum, Haya, Michael D. Stensland, Zhongyun Zhao, & Bruce J. Kinon. (2005). Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia. BMC Psychiatry. 5(1). 3–3. 63 indexed citations

15.

Ascher‐Svanum, Haya, Michael D. Stensland, Bruce J. Kinon, & Gary D. Tollefson. (2005). Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic. Journal of Psychopharmacology. 19(6_suppl). 110–117. 48 indexed citations

16.

Juster, Iver A., Michael D. Stensland, Lisa H. Brauer, & Paul Thuras. (2005). Use of administrative data to identify health plan members with unrecognized bipolar disorder: a retrospective cohort study.. PubMed. 11(9). 578–84. 3 indexed citations

17.

Tunis, Sandra L., Haya Ascher‐Svanum, Michael D. Stensland, & Bruce J. Kinon. (2004). Assessing the Value of Antipsychotics for Treating Schizophrenia. PharmacoEconomics. 22(1). 1–8. 43 indexed citations

18.

Ascher‐Svanum, Haya, Baojin Zhu, Michael D. Stensland, & K.L. Sterling. (2003). Clinical Comparability of Schizophrenia Patients at Two Public Mental Health Systems. Administration and Policy in Mental Health and Mental Health Services Research. 30(3). 231–245.

19.

Holroyd, Kenneth A., Francis O’Donnell, Michael D. Stensland, et al.. (2001). Management of Chronic Tension-Type Headache With Tricyclic Antidepressant Medication, Stress Management Therapy, and Their Combination. JAMA. 285(17). 2208–2208. 297 indexed citations

20.

Holroyd, Kenneth A., et al.. (2000). Psychosocial Correlates and Impact of Chronic Tension‐type Headaches. Headache The Journal of Head and Face Pain. 40(1). 3–16. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact